P. Pandya, R. Snijders, S. Johnson, M. Brizot, and K. Nicolaides, Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation, Br J Obstet Gynaecol, vol.102, pp.957-62, 1995.

M. Bogart, M. Pandian, and O. Jones, Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenat Diagn, vol.7, pp.623-653, 1987.

I. Merkatz, H. Nitowsky, J. Macri, and W. Johnson, An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities, Am J Obstet Gynecol, vol.148, pp.886-94, 1984.

N. Wald, H. Watt, and A. Hackshaw, Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters, N Engl J Med, vol.341, pp.461-468, 1999.

E. Alsat, J. Guibourdenche, D. Luton, and F. Frankenne, Evain-Brion D. Human placental growth hormone, Am J Obstet Gynecol, vol.177, pp.1526-1560, 1997.

S. Handwerger, The physiology of placental lactogen in human pregnancy, Endocrinology, vol.12, pp.329-365, 1991.

J. Jameson and A. Hollenberg, Regulation of chorionic gonadotropin gene expression, Endocr Rev, vol.14, pp.203-224, 1993.

H. Kliman, J. Nestler, E. Sermasi, J. Sanger, and I. J. Strauss, Purification, characterization, and in vitro differenciation of cytotrophoblasts from human term placentae, Endocrinology, vol.118, pp.1567-82, 1986.

E. Alsat, V. Mirlesse, C. Fondacci, and M. Dodeur, Evain-Brion D. Parathyroid hormone increases epidermal growth factor receptors in cultured human trophoblastic cells from early and term placenta, J Clin Endocrinol Metab, vol.73, pp.288-94, 1991.

P. Kaufmann, I. ;. Scheffen, and . Orlando, Neonatal and fetal medicine: physiology and pathophysiology

T. Eldar-geva, A. Hochberg, N. Degroot, and D. Weinstein, High maternal serum chorionic gonadotropin level in Downs' syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts, J Clin Endocrinol Metab, vol.80, pp.3528-3559, 1995.

J. Frendo, M. Vidaud, J. Guibourdenche, D. Luton, F. Muller et al., Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down syndrome, J Clin Endocrinol Metab, vol.85, pp.3700-3707, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00128454

N. Massin, J. Frendo, J. Guibourdenche, D. Luton, Y. Giovangrandi et al., Defect of syncytiotrophoblast formation and hCG expression in Down's syndrome, Placenta, vol.22, pp.93-100, 2001.

K. Benirschke and P. Kaufmann, Pathology of the human placenta, pp.22-70, 2000.

D. Oberweiss, Y. Gillerot, L. Koulischer, J. Hustin, and P. E. , Le placenta des Trisomie 21 dans le dernier trimestre de la gestation, J Gynecol Obstet Biol Reprod, vol.12, pp.345-354, 1983.

L. Roberts, N. Sebire, D. Fowler, and K. Nicolaides, Histomorphological features of chorionic vill at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies, Placenta, vol.21, pp.678-83, 2000.

J. Frendo, P. Thérond, T. Bird, N. Massin, F. Muller et al., Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation, Endocrinology, vol.142, pp.3638-3686, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00128447

J. Frendo, P. Therond, J. Guibourdenche, and M. Vidaud, Evain-Brion D. Implication of copper zinc superoxide dismutase (SOD-1) in human placenta development, Ann N Y Acad Sci, vol.973, pp.297-301, 2002.

P. Thérond, P. Gerbaud, S. Dimon, W. Anderson, D. Evain-brion et al., Antioxidant enzymes in psoriatic fibroblasts and erythrocytes, J Invest Dermatol, vol.106, pp.1325-1333, 1996.

J. Frendo, J. Guibourdenche, G. Pidoux, M. Vidaud, D. Luton et al., Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy, J Clin Endocrinol Metab, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00128419

J. Guibourdenche, A. Tarrade, I. Laurendeau, C. Rochette-egly, P. Chambon et al., Retinoids stimulate leptin synthesis and secretion in human syncytiotrophoblast, J Clin Endocrinol Metab, vol.85, pp.2550-2555, 2000.

H. Masuzaki, Y. Ogawa, N. Sagawa, K. Hosoda, T. Matsumoto et al., Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans, Nat Med, vol.3, pp.1029-1062, 1997.

J. Blond, D. Lavillette, V. Cheynet, O. Bouton, G. Oriol et al., An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor, J Virol, vol.74, pp.3321-3330, 2000.

S. Mi, X. Lee, X. Li, G. M. Veldman, H. Finnerty et al., Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis, Nature, vol.403, pp.785-794, 2000.

J. Frendo, D. Olivier, V. Cheynet, J. Blond, M. Vidaud et al., Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation, Mol Cell Biol, vol.23, pp.3566-74, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00128429

L. Cronier, J. Frendo, N. Defamie, G. Pidoux, G. Bertin et al., Requirement of gap junctional intercellular communication for human villous trophoblast differentiation, Biol Reprod, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-02556169

J. Frendo, L. Cronier, G. Bertin, J. Guibourdenche, M. Vidaud et al., Involvement of connexin 43 in human trophoblast cell fusion and differentiation, J Cell Sci, vol.116, pp.3413-3434, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00128436

S. Getsios and C. Maccalman, Cadherin-11 modulates the terminal differentiation and fusion of human trophoblastic cells in vitro, Dev Biol, vol.257, pp.41-54, 2003.

E. Alsat, P. Wyplosz, A. Malassiné, J. Guibourdenche, D. Porquet et al., Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast, in vitro, J Cell Physiol, vol.168, pp.346-53, 1996.

A. Esterman, M. Greco, Y. Mitani, T. Finlay, F. Ismail-beigi et al., The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism, Placenta, vol.18, pp.129-165, 1997.

D. Nelson, R. Johnson, S. Smith, E. Anteby, and Y. Sadovsky, Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta, Am J Obstet Gynecol, vol.180, pp.896-902, 1999.

C. Jones and C. Fox, An ultrastructural and ultrahistochemical study of the placenta in maternal essential hypertension, Placenta, vol.2, pp.193-204, 1981.

F. Van-der-veen and C. Fox, The human placenta in idiopathic intrauterine growth retardation: a light and electron microscopic study, Placenta, vol.4, pp.65-73, 1983.

T. Finkel, Oxygen radicals and signaling, Curr Opin Cell Biol, vol.10, pp.248-53, 1998.

P. Sinet, J. Couturier, B. Dutrillaux, M. Poissonnier, O. Raoul et al., Trisomy 21 and superoxide dismutase-1 (IPO-A). Tentative localization of sub-band 21Q22.1, Exp Cell Res, vol.97, pp.47-55, 1976.

L. Gilles, C. Ferradini, J. Foos, J. Pucheault, D. Allard et al., The estimation of red cell superoxide dismutase activity by pulse radiolysis in normal and trisomic 21 subjects, FEBS Lett, vol.69, pp.55-63, 1976.

P. Sinet, F. Lavelle, A. Michelson, and H. Jerome, Superoxide dismutase activities of blood platelet in trisomy 21, Biochem Biophys Res Commun, vol.67, pp.904-913, 1975.

W. Feaster, L. Kwok, and C. Epstein, Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21, Am J Hum Genet, vol.29, pp.563-70, 1977.

J. Muchova, M. Sustrova, I. Garaiova, A. Liptakova, P. Blazicek et al., Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down syndrome patients, Free Radic Biol Med, vol.31, pp.499-508, 2001.

M. Pastor, C. Sierra, M. Dolade, E. Navarro, N. Brandi et al., Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients, Clin Chem, vol.44, pp.924-933, 1998.

M. Percy, A. Dalton, V. Markovic, D. Mclachlan, J. Hummel et al., Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease, Am J Med Genet, vol.35, pp.459-67, 1990.

S. Banerjee, A. Smallwood, G. Nargund, and S. Campbell, Placental morphogenesis in pregnancies with Down's syndrome might provide a clue to pre-eclampsia, Placenta, vol.23, pp.172-176, 2002.

G. Burton, J. Hempstock, and E. Jauniaux, Oxygen, early embryonic metabolism and free radical-mediated embryopathies, Reprod Biomed Online, vol.6, pp.84-96, 2003.

Y. Wang and S. Walsh, Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia, Placenta, vol.22, pp.206-218, 2001.

E. Jauniaux, S. Bao, A. Eblen, X. Li, Z. M. Lei et al., HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21, Mol Hum Reprod, vol.6, pp.5-10, 2000.

D. Newby, D. A. Aitken, J. A. Crossley, A. G. Howatson, J. N. Macri et al., Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies, Prenat Diagn, vol.17, pp.941-51, 1997.